poisar

Stocks · News reference

Colony Bankcorp Q2 Adj. EPS $0.52 Beats $0.47 Estimate, Sales $42.027M Beat $40.900M Estimate

BenzingaBenzinga Newsdesk

Colony Bankcorp (NASDAQ:CBAN) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.47 by 8.33 percent. This is a 13.04 percent increase over earnings of $0.46 per share from the

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — COLONY BANKCORP INC (CBAN)

    Filed: 2026-09-17 AccNo: 0001104659-26-108432 Size: 419 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

  2. BenzingaBenzinga Insights

    Transcript: Colony Bankcorp Q2 2026 Earnings Conference Call

    Colony Bankcorp (NASDAQ:CBAN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts

  3. Globenewswire IncJuan Monteverde, Monteverde & Associates Pc

    $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger – AUUD, TECH, CZR and CBAN

    Monteverde & Associates PC is investigating four major merger and acquisition deals to determine if they are fair to shareholders: Auddia's merger with McCarthy Finney (1:1 stock exchange), Bio-Techne's sale to Merck KGaA ($73/share), Caesars Entertainment's sale to Fertitta Gaming ($31/share plus ticking consideration), and Colony Bankcorp's merger with First Reliance Bancshares ($19.75 cash or 0.94 stock exchange).